LSA
DGX icon

L & S Advisors’s Quest Diagnostics DGX Stock Holding History

L & S Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,993
Closed -$3.11M – 288
2021
Q4 		$3.11M Buy
+17,993
New +$2.74M 0.34% 84
2020
Q3 		– Sell
-14,279
Closed -$1.63M – 314
2020
Q2 		$1.63M Sell
14,279
-175
-1% -$18.6K 0.24% 108
2020
Q1 		$1.16M Buy
+14,454
New +$1.5M 0.22% 108

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

L & S Advisors's DGX Position: Q1 2022 in Review

L & S Advisors sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 17,993 shares — an estimated $3.11M sold.

L & S Advisors first reported a position in DGX in Q1 2020 and held it in 3 quarters. The position peaked at $3.11M in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • L & S Advisors reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • L & S Advisors sold 17,993 Quest Diagnostics shares in Q1 2022, an estimated $3.11M.
  • L & S Advisors first reported a position in Quest Diagnostics in Q1 2020 and held it in 3 quarters.
  • L & S Advisors's Quest Diagnostics position peaked at $3.11M in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on L & S Advisors's 13F filing for Q1 2022, filed 11 May 2022.